NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.03, $0.01 better than the analyst estimate of $0.02. Revenue for the quarter came in at $187.8 million versus the consensus estimate of $183.74 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.